3-Fluoro-2-methylphenol | CAS:443-87-8

We serve 3-Fluoro-2-methylphenol CAS:443-87-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3-Fluoro-2-methylphenol

Chemical Name:3-Fluoro-2-methylphenol
CAS.NO:443-87-8
Synonyms:3-Fluoro-2-methylphenol
3-Fluoro-o-cresol
2-Fluoro-6-hydroxytoluene
3-Fluoro-2-methylphenol
 
Physical and Chemical Properties:
Density 1.2±0.1 g/cm3
Boiling Point 187.9±20.0 °C at 760 mmHg
Melting Point 53.2-53.9ºC
Molecular Formula C7H7FO
Molecular Weight 126.128
Flash Point 78.5±10.5 °C
Vapour Pressure 0.4±0.4 mmHg at 25°C
Index of Refraction 1.520
 
Specification:
Appearance:Colorless to light yellow liquid
Assay:≥98.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.



Contact us for information like 3-Fluoro-2-methylphenol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Fluoro-2-methylphenol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Fluoro-2-methylphenol Use and application,3-Fluoro-o-cresol technical grade,usp/ep/jp grade.


Related News: “So far, the finding is still under preliminary study, and a large number of experiments is needed to test if it is effective on patients,” it said, citing the WHO in saying that no proven effective drugs to prevent or treat the Wuhan coronavirus are currently available.4-Amino-2-chloropyridine manufacturer Fate Therapeutics, Inc. recently announced new in vivo preclinical data for FT819, its first off-the-shelf, iPSC-derived chimeric antigen receptor (CAR) T-cell product candidate, at the 61st American Society of Hematology (ASH) Meeting and Exposition in Orlando, FL.tetradecane-1-thiol supplier Fate Therapeutics, Inc. recently announced new in vivo preclinical data for FT819, its first off-the-shelf, iPSC-derived chimeric antigen receptor (CAR) T-cell product candidate, at the 61st American Society of Hematology (ASH) Meeting and Exposition in Orlando, FL.4-bromo-9,9'-spirobi[fluorene] vendor ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment’s chemistry, manufacturing and controls process, but not its safety.The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented.